- Home
- RSI vs SRPT Comparison
RSI vs SRPT Comparison
Compare RSI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RSI | SRPT |
|---|---|---|
| Founded | 2012 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RSI | SRPT |
|---|---|---|
| Price | $26.25 | $16.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 29 |
| Target Price | ★ $28.20 | $25.85 |
| AVG Volume (30 Days) | 2.2M | ★ 2.6M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 933.33 | N/A |
| EPS | 0.08 | ★ 2.88 |
| Revenue | $1,134,428,000.00 | ★ $2,198,237,000.00 |
| Revenue This Year | $25.44 | N/A |
| Revenue Next Year | $14.27 | N/A |
| P/E Ratio | $339.25 | ★ $5.85 |
| Revenue Growth | ★ 22.76 | 15.58 |
| 52 Week Low | $11.76 | $10.42 |
| 52 Week High | $29.24 | $43.92 |
Technical Indicators
Market Signals| Indicator | RSI | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 50.18 | 33.11 |
| Support Level | $26.00 | $15.70 |
| Resistance Level | $29.24 | $19.62 |
| Average True Range (ATR) | 0.99 | 1.01 |
| MACD | -0.33 | -0.34 |
| Stochastic Oscillator | 16.67 | 5.34 |
Price Performance
Historical ComparisonAbout RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.